A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes. (8th November 2018)

• Record Type: Journal Article
• Authors: Homma, Gosuke; Daimon, Takashi
• Is Part Of: Pharmaceutical statistics. Volume 18:Number 2(2019)
• Page Start: 184
• Page End: 197
• Publication Date: 2018-11-08
• Subjects: count -- multiple sclerosis -- overdispersion -- placebo response -- SPCD; Pharmacy -- Statistical methods -- Periodicals; Pharmacy -- Statistics -- Periodicals; 615.10727
• DOI: 10.1002/pst.1913
• Languages: English
• ISSNs: 1539-1604

Abstract

Abstract : In placebo‐controlled, double‐blinded, randomized clinical trials, the presence of placebo responders reduces the effect size for comparison of the active drug group with the placebo group. An attempt to resolve this problem is to use the sequential parallel comparison design (SPCD). Although there are SPCDs with dichotomous or continuous outcomes, an SPCD with negative binomial outcomes—with which investigators deal eg, in clinical trials involving multiple sclerosis, where the investigators are still concerned about the presence of placebo responders—has not yet been discussed. In this article, we propose a simple test for the treatment effect in clinical trials with an SPCD and negative binomial outcomes. Through simulations, we show that the analysis method achieves the nominal type I error rate and power, whereas the sample size calculation provides the sample size with adequate power accuracy.